📈 Stocks
Parabilis Eyes $475 Million IPO on US Exchange to Fund Cancer Drug Trials
(47 days ago)
Cancer drugmaker Parabilis aims to raise $475 million in a US IPO, testing biotech investor sentiment as the company progresses its oncology…